Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Method Detects Urinary Tract Infections

By LabMedica International staff writers
Posted on 22 May 2012
The reliability of a rapid detection method for urinary tract infection (UTI) has been compared with the reference standard streaked agar plate method. More...


The novel CultureStat Rapid UTI Detection System (CSRUDS) consists of a vacuum-sealed glass ampoule containing trypticase soy broth dry media and triphenyl tetrazolium chloride, a chromophore indicator sensitive to dehydrogenase.

Scientists at Columbia University Medical Center, (New York, NY, USA) working with others, selected 980 clean catch urine samples into specimen cups during a 30-day period. Each specimen was streaked on separate 5% sheep blood agar plates and simultaneously a 7-mL aliquot of each fresh urine specimen was processed using the CSRUDS. A spectrophotometer linked to a computer and a bar code scanner was used to identify and test each urine sample.

Positive UTI conditions were accurately identified by both CSRUDS and agar streak plate methods. CSRUDS accurately identified UTI negative conditions with 99.3% reliability at 90 minutes. The negative predictive value of CSRUDS was 99.2% at 30 minutes. The bacterial plating results revealed that 413 (58.8%) of the CSRUDS negative group demonstrated no bacterial growth at all, and 289 (41.2%) of the CSRUDS negative group showed some degree of bacterial growth. Of the 289 samples, 82 (28.4%, including one of the six CSRUDS false-negative samples), showed bacterial growth in the 50,000 colony forming units (CFU) range and 200/289 (69.2%), including the other five false-negative CSRUDS samples, had CFU counts of 1,000-49,000 CFUs or mixed flora. Of the 289, 7 (2.4%) had growth greater than 100,000 colonies/mL.

The author concluded that he novel rapid detection system evaluated in this test program, the CSRUDS and MB80CSENC spectrophotometer (MicroBionetics, Eldersburg, MD, USA) provided UTI negative/positive same-day results within 90 minutes from the start of the test, with a highly reliable negative predictive value within 30 minutes for most patients. Because it is such a rapid test, contamination at urine collection is unlikely to affect the results of the assay. Specimen transport and delays in processing the urine sample are obviated because the test can be immediately performed in the urologist's office where the specimen was collected. The study was published in the April 2012 issue of the journal Urology.

Related Links:
Columbia University Medical Center
MicroBionetics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes

Patients with solid tumors often undergo molecular profiling to identify alterations that can guide therapy. This testing may also reveal constitutional cancer-predisposing DNA variants, which are present... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The acquisition of Proscia advances Agilent’s efforts to expand its pathology portfolio and strengthens its competitive position in a rapidly growing market.

Agilent Completes Acquisition of Digital Pathology Platform Developer Proscia

Agilent Technologies has completed its acquisition of Proscia, a provider of digital pathology software for clinical and life sciences applications. The transaction involved a cash payment of USD 240 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.